FDA
approval
· 2017-10-10
FDA Approved: LO LOESTRIN FE — Supplemental Application (Allergan, Inc.)
Summary
The FDA approved a supplemental application for LO LOESTRIN FE from Allergan, Inc. The product is a combination oral contraceptive used for birth control.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LO LOESTRIN FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE)